DABIGATRAN ETEXILATE MESYLATE | A215233 | ALEMBIC PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.8961
per ea
Lowest NADAC/Unit
$0.7152
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 62332063506DABIGATRAN ETEXILATE 110 MG CP | $0.8961 | EA | Generic | — | 2026-10-21 |
| 62332063560DABIGATRAN ETEXILATE 110 MG CP | $0.8961 | EA | Generic | — | 2026-10-21 |
| 62332063606DABIGATRAN ETEXILATE 150 MG CP | $0.8005 | EA | Generic | — | 2026-10-21 |
| 62332063660DABIGATRAN ETEXILATE 150 MG CP | $0.8005 | EA | Generic | — | 2026-10-21 |
| 62332063406DABIGATRAN ETEXILATE 75 MG CAP | $0.7152 | EA | Generic | — | 2026-10-21 |
| 62332063460DABIGATRAN ETEXILATE 75 MG CAP | $0.7152 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.